b'HADVERTISER GUIDESun PharmaSun Pharma is the fourth largest specialty generic pharmaceutical com-pany in the world with global revenues of over US $5 billion. Supported by more than 38,000 employees and 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.Over the last two decades, Sun Pharma has established itself as a leading player in the U.S. generics market. We are the 8th largest generics pharmaceutical company in the U.S, and we are rapidly ramping up our presence in the specialty branded market. For further information, please visitwww.sunpharma.com.Taiho OncologyThe mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer,their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncologys growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent companys European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information,visitwww.taihooncology.comQuestions, contact Andrew [email protected]
Support Our AdvertisersThe 2023 Directory of Federal Medical Treatment Facilitiesis provided free to the readers of U.S. Medicine, at no costto the federal government or U.S. taxpayer.U.S. Medicine is grateful to these advertisers that make this publication possible.'